Aquestive Therapeutics, Inc. (AQST) vs Collegium Pharmaceutical, Inc. (COLL)

Aquestive Therapeutics, Inc. and Collegium Pharmaceutical, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $737.1M against $605.0M — 1.2× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 14.7×. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against 14.3%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −144.6%) and the higher return on invested capital (7.85% vs 0.00%). Across the 18 metrics below, Collegium Pharmaceutical, Inc. leads on 13 and Aquestive Therapeutics, Inc. on 5.

Valuation

Metric AQST COLL Drug Manufacturers Specialty & Generic median
P/E n/m 14.73 20.14
P/S 10.82 0.90 2.25
P/B n/m 2.34 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 4.29 12.29
EV/Sales 9.93 2.07 2.56
Earnings yield (13.89%) 6.79% (2.99%)
Free cash flow yield (7.85%) (5.46%) 0.00%

Profitability

Metric AQST COLL Drug Manufacturers Specialty & Generic median
Gross margin 67.04% 60.02% 53.94%
Operating margin (97.52%) 19.48% 0.00%
Net margin (144.63%) 5.93% 0.00%
Free cash flow margin (84.95%) 40.62% 0.00%
Return on equity 121.12% 17.61% (0.40%)
Return on assets (69.29%) 2.57% (3.32%)
Return on invested capital 0.00% 7.85% 0.00%

Growth

Metric AQST COLL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 22.56% 14.31% 10.01%
EPS growth (last fiscal year) (52.94%) (6.99%) —
Revenue growth, 5-year CAGR (0.58%) 20.28% 6.74%
Net income growth, 5-year CAGR 0.00% 18.64% 0.00%

Health

Metric AQST COLL Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) 3.50 0.05
Current ratio 7.19 1.03 2.31
Net debt to EBITDA 1.57 1.00 0.85

Dividend

Metric AQST COLL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AQST COLL Drug Manufacturers Specialty & Generic median
Market cap 604.97m 737.06m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack